An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Department of Pathology and Laboratory Medicine and Department of Medicine, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine, Lebanon, New Hampshire 03766, USA.
1 Department of Pathology and Laboratory Medicine and Department of Medicine, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine, Lebanon, New Hampshire 03766, USA.
A 55-yr-old woman presented with abdominal bloating for approximately 1 year. Imaging studies showed a cyst in the body of the pancreas with proximal pancreatic ductal dilation. An endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) was performed. Cytologic findings from the cyst fluid were consistent with a mucinous neoplastic cyst, and the possibility of malignancy could not be entirely excluded. A KRAS mutation analysis was performed on the cyst fluid using the Idylla system and circulating tumor KRAS (ctKRAS) cartridge (Biocartis, Mechelen, Belgium), which tests for actionable mutations in exons 2, 3, and 4 of the KRAS gene. Idylla testing detected a KRAS G12D mutation in the cyst fluid. The patient subsequently underwent a distal subtotal pancreatectomy with splenectomy. Microscopic examination of the resected tissue revealed an intraductal papillary mucinous neoplasm (IPMN) with an associated invasive carcinoma. KRAS testing on the resected tumor tissue confirmed the G12D mutation detected in the cyst fluid earlier. The described rapid testing of KRAS directly from the pancreatic cyst fluid can complement cytology assessment to classify pancreatic cysts more reliably and can potentially be of significant help when other cyst findings are nondiagnostic.
( A ) Endoscopic ultrasound (EUS) showing a 29-mm septated cystic lesion seen…
Figure 1.
(A) Endoscopic ultrasound (EUS) showing a 29-mm septated cystic lesion seen in the pancreatic body, associated with upstream ductal dilation. The outer wall of the lesion was thin. There was no associated mass. (B) Mucinous/gastric foveolar-type epithelial cells in a small cluster. (C) Focal cytologic and architecture atypia and background necrosis. (D) Cell block showing a few clusters of mucinous/gastric foveolar-type epithelial cells and background necrosis. (E) Cyst at the body of pancreas measuring 4.1 × 2.2 × 2.0 cm with solid area extending into the pancreatic duct (arrow). (F) IPMN (arrowhead) with an associated invasive carcinoma (arrow). (G) Invasive carcinoma with perineural invasion (arrow).
Al-Turkmani MR, Godwin KN, Peterson JD, Tsongalis GJ. 2018. Rapid somatic mutation testing in colorectal cancer by use of a fully automated system and single-use cartridge: a comparison with next-generation sequencing. J Appl Lab Med 3: 178–184. 10.1373/jalm.2018.026278
-
DOI
-
PubMed
Bournet B, Muscari F, Buscail C, Assenat E, Barthet M, Hammel P, Selves J, Guimbaud R, Cordelier P, Buscail L. 2016. KRAS G12D mutation subtype is a prognostic factor for advanced pancreatic adenocarcinoma. Clin Transl Gastroenterol 7: e157 10.1038/ctg.2016.18
-
DOI
-
PMC
-
PubMed
Faias S, Duarte M, Albuquerque C, da Silva JP, Fonseca R, Roque R, Dias Pereira A, Chaves P, Cravo M. 2018. Clinical impact of KRAS and GNAS analysis added to CEA and cytology in pancreatic cystic fluid obtained by EUS-FNA. Dig Dis Sci 63: 2351–2361. 10.1007/s10620-018-5128-y
-
DOI
-
PubMed
Khalid A, Zahid M, Finelstein SD, LeBlanc JK, Kaushik N, Ahmad N, Brugge WR, Edmundowicz SA, Hawes RH, McGrath KM. 2009. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 69: 1095–1102. 10.1016/j.gie.2008.07.033
-
DOI
-
PubMed
Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, Arun BK, Litton JK. 2015. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer 121: 269–275. 10.1002/cncr.29041
-
DOI
-
PMC
-
PubMed